# COVAG - Covid-19 Antigen Study - the Diagnostic Efficacy of SARS-CoV-2 Rapid Detection Tests

> **NCT05074017** · — · COMPLETED · sponsor: **Synlab Holding Deutschland GmbH** · enrollment: 2222 (actual)

## Conditions studied

- COVID-19
- SARS-CoV2 Infection
- SARS (Disease)

## Interventions

- **DEVICE:** 3 nasopharyngeal swab

## Key facts

- **NCT ID:** NCT05074017
- **Lead sponsor:** Synlab Holding Deutschland GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-01
- **Primary completion:** 2021-03-31
- **Final completion:** 2021-03-31
- **Target enrollment:** 2222 (ACTUAL)
- **Last updated:** 2021-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05074017

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05074017, "COVAG - Covid-19 Antigen Study - the Diagnostic Efficacy of SARS-CoV-2 Rapid Detection Tests". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05074017. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*